TY  - JOUR

T1  - A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer.

JO  - Journal of Clinical Oncology

PY  - 2020/02/20

AU  - James ND

AU  - Pirrie S

AU  - Liu W

AU  - Ford D

AU  - Zarkar A

AU  - Southgate E

AU  - Desai A

AU  - Hussain SA

ED  - 

DO  - DOI: 10.1200/jco.2020.38.6_suppl.491

VL  - 38

IS  - 6_suppl

SP  - 491

EP  - 491

Y2  - 2024/12/21

ER  -